Should genetic analysis in newborn screening and a heterozygote test for hyperphenylalaninaemia be recommended? An italian study

Journal of Medical Screening

Volumn 6, Issue 4, 1999, Pages 193-194

  Rottoli, A ^a   Gianni M L ^a   Verduci, E ^a   Biondi, M L ^b   Fiori, L ^a   Giovannini, M ^a   Riva, E ^a  

^a SAN PAOLO HOSPITAL   (Italy)

^b Medical School   (Italy)

Author keywords

Genetic screening; Heterozygote test; Hyperphenylalaninaemia

Indexed keywords

CELL DNA; PHENYLALANINE 4 MONOOXYGENASE;

ADULT; ARTICLE; CHILD; CONTROLLED STUDY; COST BENEFIT ANALYSIS; DIAGNOSTIC VALUE; DNA DETERMINATION; FEMALE; GENE FREQUENCY; GENE MUTATION; HEALTH CARE COST; HETEROZYGOTE DETECTION; HUMAN; HUMAN CELL; HYPERPHENYLALANINEMIA; INFANT; ITALY; MAJOR CLINICAL STUDY; MALE; NEWBORN; NEWBORN SCREENING; PHENYLKETONURIA;

EID: 0033375977     PISSN: 09691413     EISSN: None     Source Type: Journal    
DOI: 10.1136/jms.6.4.193     Document Type: Article

References (13)

1. Scriver CR, Kaufman S, Woo SLC. The hyperphenylalaninemias. In: Scriver CR, Beaudet AL, Sly WS, eds. The metabolic basis of inherited disease. New York: McGraw-Hill, 1989:495-546.
2. Lidsky AS, Law ML, Morse HG, et al. Regional mapping of the human phenylalanine hydroxylase gene and the PKU locus on chromosome 12. Proc Natl Acad Sci USA 1985;82:6221-5.
3. Hoang L, Byck S, Prevost L, et al. PAH mutation analysis consortium database for disease-producing and other allelic variation at the human PAH locus. Nucleic Acids Res 1996;24:127-31.
4. Lehmann WD. Progress in the identification of the heterozygote in phenylketonuria. J Pediatr 1989;114:915-24.
5. Dianzani I, Giannattasio S, De Sanctis L, et al. Characterization of phenylketonuria alleles in the Italian population. Eur J Hum Genet 1995;3:294-302.
6. Di Lella AG, Huang WM, Woo SLC. Screening for phenylketonuria mutations by DNA amplification with the polymerase chain reaction. Lancet 1988;i:497-9.
7. Guldberg P, Romano V, Ceratto N, et al. Mutational spectrum of phenylalanine hydroxylase deficiency in Sicily: implications for diagnosis of hyperphenylalaninemia in Southern Europe. Hum Mol Genet 1993;2:1703-7.
8. Eiken HG, Odland E, Boman H, et al. Application of natural and amplification created restriction sites for the diagnosis of PKU mutations. Nucleic Acids Res 1991;19: 1427-30.
9. Rottoli A, Gianni ML, Verduci E, et al. Human gene mutations. Hum Genet 1999;104:529.
10. Guldberg P, Henriksen KF, Guttler F. Molecular analysis of phenylketonuria in Denmark: 99% of the mutations detected by denaturing gradient gel electrophoresis. Genomics 1993;17:141-6.
11. Zekanowski C, Nowacka M, Zgulska M, et al. Frequencies of the most common mutations responsible for phenylketonuria in Poland. Mol Cell Probes 1994;8:324-4.
12. O'Neill CA, Einsensmith RC, Croke DT, et al. Molecular analysis of PKU in Ireland. Acta Paediatr Suppl 1994;407: 43-4.
13. Guldberg P, Rey F, Zschocke J, et al. A European multicenter study of phenylalanine hydroxylase deficiency: classification of 105 mutations and a general system for genotype based prediction of metabolic phenotype. Am J Hum Genet 1988;63:71-9.